Chrisy Ngilneii's Profile

B.Sc (Psychology), M.A (Sociology), Ph.D. (Epidemiology)

Chrisy Ngilneii

Chrisy is a Ph.D. Research Scholar at the University of Madras. Her area of specialization is in Epidemiology of Cancer. Writing is her passion. She has published scholarly articles on health topics in prominent journals, and had also edited two books in the academic field which are now available on view more..

Written / Edited / Medically Reviewed

Yellow Fever may be Contagious Longer Than Previously Thought

Yellow Fever may be Contagious Longer Than Previously Thought

Yellow fever virus is detected in urine and semen almost a month after infection. The confirmation suggests the virus may be contagious for a period which stretches longer than previously thought.

Health Watch
Breastfeeding may Have Long-term Benefits on Mothers’ Heart Health

Breastfeeding may Have Long-term Benefits on Mothers’ Heart Health

Breastfeeding may have long-term heart health benefits for some moms. Lactating for six months shows improved markers of cardiovascular health a decade later. Women may be able to reduce their risk of heart disease by breastfeeding for at least six months per pregnancy

Health Watch
Obesity may Shorten Life and Increase Risk of Death from Heart Disease

Obesity may Shorten Life and Increase Risk of Death from Heart Disease

Obesity is associated with shorter longevity and significantly increased risk of cardiovascular morbidity and mortality compared with people with normal body mass index - BMI. Overweight individuals live greater proportion of their lives lived with heart disease.

Health Watch
Potential Therapy for Type-1 Diabetes Found in Pancreatic Cells

Potential Therapy for Type-1 Diabetes Found in Pancreatic Cells

Unique pancreatic stem cells have potential to regenerate beta cells and respond to glucose. These findings pave way for regenerative cell therapies in type-1 diabetes patients.

Health Watch
Best Treatment for Mixed Phenotype Acute Leukemia Identified

Best Treatment for Mixed Phenotype Acute Leukemia Identified

Patients initially treated with acute lymphoblastic leukemia (ALL) therapy are more likely to achieve a complete remission than acute myeloid leukemia (AML)-treated patients.

Health Watch